The primary antibodies were as follows: B220 (Rat, 1:200, Biolegend #103202), CD11b (Rabbit, 1:200, Abcam #133357), CD3 (Rabbit, 1:200, Abcam #16669), CD4 (Rat, 1:200, ThermoFisher #14-9766-82), CD8 (Rat, 1:100, ThermoFisher, #14-0808-82), IBA1 (Rabbit, 1:200, VWR #100369-764), and MPO (Rabbit, 1:500, Abcam, #ab208670)
Vegetarians, vegans, elders, people who drink alcohol, people who have digestive issues and who are taking certain medications
Concerns about B12 status in weight loss medication users stem primarily from experience with metformin and certain bariatric surgical procedures
Control of protein stability by post-translational modifications
Does not interact with known drug-metabolising enzymes, which reduces the probability of drug-drug interactions, but long-term metabolic consequences of sustained NNMT suppression in humans remain uncharacterised
InstaRelease Delivery Technology